U.S. Appeals Court Rules Trump Can Remove Members of Key Federal Labor Boards 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
Judge Orders Return of Seized Evidence in Comey-Related Case, DOJ May Seek New Warrant 
Federal Judge Blocks Trump Administration’s Pause on New Wind-Energy Permits 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Colombia’s Clan del Golfo Peace Talks Signal Mandatory Prison Sentences for Top Leaders 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
U.S. Justice Department Orders Intensified Probe Into Antifa and Domestic Extremist Groups 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
Federal Judge Orders Restoration of SEVIS Status for Tufts PhD Student Rumeysa Ozturk 
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
Environmental Group Sues to Block Trump Image on U.S. National Park Passes 
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran 
Trump Claims Pardon for Tina Peters Despite No Legal Authority 
For decades, cannabis or marijuana as it is more commonly known has been treated as an illegal substance that could land offenders in prison for a long time. After the movement to make marijuana legal gained steam, several U.S. states have since changed their tune and legalized its use. Now, a pharmaceutical company is considering developing drugs with cannabis as one of the main ingredients.
The drug company in question is GrowBlox Life Sciences LLC and it recently announced that it will be creating a new medication for curing and preventing cardiovascular diseases using marijuana as one of the ingredients, Futurism reports. One of the main driving forces behind the move is Dr. Alexander Stokes from the University of Hawaii.
In 2015, Stokes received a patent for developing a therapy method involving the treatment of heart diseases with cannabis as the principal component. When asked about it a year ago, Stokes explained that the main problems that cause heart disease in the first place have to do with increasing the strain placed on it. By giving the heart a bit of support, this workload can be redistributed.
“Many types of diseases ultimately affect the heart by making it work harder,” Stokes had said at the time. “The heart muscle compensates by getting bigger (cardiac hypertrophy). The heart becomes stiffer and less functional and eventually starts to fail. We have a way of protecting the heart with a completely new therapeutic approach—a therapy that allows the heart to compensate for the extra work it needs to perform, without losing function and failing.”
The main idea is to basically bind the receptor called TRPV1 with the cannabinoid in marijuana. Since TRPV1 is considered one of the main things that ultimately contribute to heart failure, keeping it in check will go a long way towards preventing a heart attack.
